A report from Open Markets Institute Senior Fellow Sally Hubbard argues policymakers must ensure either that AI agents work on behalf of users, or that users understand when AI agents are working on behalf of a corporation.
Open Markets filed an amicus brief urging the Fourth Circuit to revive antitrust claims against Johnson & Johnson, arguing the company used its acquisition of biosimilar-related patents to protect its Stelara monopoly and delay lower-cost competition.
By deepening concentration in the film and TV industry, the proposed transaction raises significant competition concerns. CMDG and Open Markets Europe call on the EU Commission to investigate the proposed merger.
In The Times’ opinion pages, Sandeep Vaheesan and Claire Kelloway explain how runaway consolidation in our food markets has kept prices high.